The approval of the expanded age range was based on data from a clinical trial which evaluated the efficacy of Gardasil (quadrivalent human papillomavirus recombinant vaccine) in 3253 women 27-45 years of age with a median duration of follow-up of 3.5 years post-dose 3.
14 million need to receive two doses of vaccine to reach goal of 80% vaccination by 2026.
From 2008 to 2015, both cervical intraepithelial neoplasia grades 2, 3 and adenocarcinoma in situ rates and cervical cancer screening declined in women age 18 to 24 years.
Cytology recommended every 3 years from age 21; different screening options from age 30 to 65.
Researchers sought to identify parental predictors of HIV vaccination in low-income adolescent Hispanic girls.
No substantive or significant associations between HPV legislation and adolescent sexual behaviors.
Vaccinated women and girls living with HIV may be at greater risk for HPV vaccine failure compared with women and girls without HIV.
Less than a year following the initial direct-to-tumor vaccine injection, all treated tumors disappeared.
Use of primary HPV testing results in significantly lower odds of CIN3 compared with cytology testing
Regardless of age, favorable survival conferred by an HPV-positive tumor status
Investigators examined parental hesitancy when discussing human papillomavirus vaccination with providers.
High-certainty evidence for protection in adolescent girls and young women aged 15 to 26 years
Clinicians using communication training and fact sheets to inform adolescents about HPV, significantly increased vaccination initiation and completion rates among their patients.
The importance of male vaccination cannot be overemphasized, because the risk of male-to-female HPV transmission is significant.
The researchers found that 2 doses of the HPV vaccine were just as protective as 3 doses.
Nitrate inhalants (poppers) associated with increased virus-associated cancer risk in HIV-uninfected MSMMay 22, 2017
Among HIV-uninfected men aged 50 to 70, heavy popper use was associated with an increased risk of virus-associated cancer with causes linked to HPV, HHV-8, and Epstein-Barr virus.
The data suggest that the vaccine may be reducing the prevalence of those infections by as high as 100%.
However, the HPV vaccine has the potential to reverse the epidemic and prevent thousands of cancers in the United States each year.
The students improved their basic knowledge of HPV and understood the benefits of the HPV vaccine.
Children younger than 15 may be given 2 HPV vaccine doses instead of 3, and the shots should be spaced at least 6 months apart.
A new HPV screening test that uses cervical cells collected for a Pap test has been approved by the FDA.
A greater understanding of the healthcare issues specific to the lesbian, gay, bisexual, and transgender community may improve the quality of care.
College-aged students may benefit from continued education regarding the spread of HPV, especially oral transmission
The new vaccine protects against 9 types of HPV and 5 cancer-causing strains.
The American Society of Clinical Oncology has released its recommendations to help improve rates of HPV vaccination worldwide.
Data collected between 2009 and 2012 show a significant decline in cases of HPV in females aged 14-19 and 20-24.
Confusion surrounds the current screening recommendations and guidelines.
A variety of factors have led to low rates of teenage boys being vaccinated for the human papillomavirus (HPV), said a report published in Pediatrics.
Human papillomavirus vaccination not linked to increase in sexually transmitted infections in adolescent femalesOctober 02, 2015
The HPV vaccination is not associated with an increase in sexually transmitted infections in adolescent females, study results suggest. The vaccine is recommended for all children 11 to 12 years old.
The Cervarix vaccine may be as effective in one or two doses as it is with three.